Huron Announces Third Quarter 2023 Earnings Release and Webcast
CHICAGO–(BUSINESS WIRE)–Global professional services firm Huron (NASDAQ: HURN) will announce its financial results for the third quarter ended September... Read more.
Vesigen Highlights Non-Human Primate Biodistribution of Non-Viral Technology and Functional Delivery of Genome Editors In Vivo at the Cracking the Code: The Dawn of Nucleic Acid Medicines Meeting
Robust uptake observed in photoreceptors and retinal pigment epithelium (RPE) of mice, minipigs, and non-human primates Additional data demonstrate rescue of acute... Read more.
1Kosmos Named Luminary in Biometric Digital Identity Prism Report
Analysts expect 1Kosmos BlockID platform’s approach to become standard for distributed digital identity verification and passwordless MFA EAST BRUNSWICK, N.J.–(BUSINESS... Read more.
Solidifi Charitable Foundation Supports Homeless Youth with $100,000 Donation to Covenant House Toronto
TORONTO–(BUSINESS WIRE)–The Solidifi Charitable Foundation (the “Foundation”) today announced that it has donated $100,000 to Covenant House Toronto.... Read more.
Seismic Releases The State of AI in Enablement: 2023 Report, Finds AI Supercharges GTM Efforts and Improves Customer Satisfaction, Despite Hurdles
New data reveals the rapid adoption of AI in enablement solutions, but not without implementation and integration challenges SAN DIEGO–(BUSINESS WIRE)–Seismic,... Read more.
Overstory Raises $14M Series A to Help Solve Climate and Biodiversity Crises
Company to expand AI-based product that reduces risks of wildfires and power outages AMSTERDAM–(BUSINESS WIRE)–Overstory, a climate tech startup that... Read more.
AI Linked to Revenue Growth: Seismic Research Reveals That 80% of Sales Leaders Expect Revenue Gains From Incorporating AI Into Go-to-Market Strategies
Data reveals that 4 in 5 sales leaders expect revenue to grow by 23% on average from AI utilisation over the next five years LONDON–(BUSINESS WIRE)–Seismic,... Read more.
Belden Introduces New Partner Alliance Ecosystem Program
Partnership between global leaders and Belden streamlines access to best-in-class solutions to maximize business value ST. LOUIS–(BUSINESS WIRE)–Belden... Read more.
Amylyx Pharmaceuticals to Present Clinical Trial Design of ORION, a Phase 3 Global Study of AMX0035 in Progressive Supranuclear Palsy (PSP), at the Neuro2023 PSP and CBD International Research Symposium
– ORION is a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating the safety, efficacy, and tolerability of AMX0035 in adults with... Read more.
On-Premise Segment Predicted to Hit $3.6 Billion by 2030 with a 15.1% CAGR, While Cloud CPQ Software Soars at 17.8% Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Configure Price Quote Software – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s... Read more.